[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.180.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 1959

The Treatment of Cancer by Perfusion

Author Affiliations

New Orleans
Tulane University School of Medicine; Charity Hospital of Louisiana; Touro Infirmary; U.S. Public Health Service Hospital.

AMA Arch Surg. 1959;79(6):963-975. doi:10.1001/archsurg.1959.04320120105012
Abstract

Technique 

Technique  Figure 3Figure 4Figure 5Figure 6

Technique  Figure 7Figure 8Figure 9Figure 10

Metastatic Melanoma  Fig. 11.—Before perfusion.Fig. 12.—Two years after perfusion.

Case 1.  —A 77-year-old white man. In 1956 malignant melanoma removed from left foot, followed by groin dissection May, 1957: Appearance of multiple dermal metastases. June, 1957: Isolated perfusion with 120 mg. phenylalanine mustard (PAM) through common femoral artery.Fig. 13.—Original lesion.Fig. 14.—Metastasis, six weeks after perfusion.Fig. 15.—Metastasis, eight weeks after perfusion.

Melanoma  Figure 16

Case 2.  —1947: Small mole (malignant melanoma) removed from right medical lower leg. 1958: Local recurrence followed by multiple excisions. Treated with TSPA intra-arterially without improvement (Fig. 16, A). December, 1958: Common femoral artery perfusion with 130 mg. PAM (1.8 mg. per kilogram of body weight). January, 1959: Many lesions disappeared (Fig. 16, B).Figure 17

Case 3.  —1957: Malignant melanoma with extensive metastases

First Page Preview View Large
First page PDF preview
First page PDF preview
×